These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20109747)

  • 1. Defect of regulatory T cells in patients with Omenn syndrome.
    Cassani B; Poliani PL; Moratto D; Sobacchi C; Marrella V; Imperatori L; Vairo D; Plebani A; Giliani S; Vezzoni P; Facchetti F; Porta F; Notarangelo LD; Villa A; Badolato R
    J Allergy Clin Immunol; 2010 Jan; 125(1):209-16. PubMed ID: 20109747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells.
    Somech R; Simon AJ; Lev A; Dalal I; Spirer Z; Goldstein I; Nagar M; Amariglio N; Rechavi G; Roifman CM
    J Allergy Clin Immunol; 2009 Oct; 124(4):793-800. PubMed ID: 19767069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of a CD4
    Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
    Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.
    Rajasekaran N; Wang N; Truong P; Rinderknecht C; Macaubas C; Beilhack GF; Shizuru JA; Mellins ED
    Arthritis Rheum; 2013 Mar; 65(3):681-92. PubMed ID: 23233229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
    Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
    Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome.
    Poliani PL; Facchetti F; Ravanini M; Gennery AR; Villa A; Roifman CM; Notarangelo LD
    Blood; 2009 Jul; 114(1):105-8. PubMed ID: 19414857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency.
    Zuber J; Viguier M; Lemaitre F; Senée V; Patey N; Elain G; Geissmann F; Fakhouri F; Ferradini L; Julier C; Bandeira A
    Gastroenterology; 2007 May; 132(5):1694-704. PubMed ID: 17484867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression.
    Fragale A; Gabriele L; Stellacci E; Borghi P; Perrotti E; Ilari R; Lanciotti A; Remoli AL; Venditti M; Belardelli F; Battistini A
    J Immunol; 2008 Aug; 181(3):1673-82. PubMed ID: 18641303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice.
    Zheng Q; Xu Y; Liu Y; Zhang B; Li X; Guo F; Zhao Y
    J Mol Med (Berl); 2009 Dec; 87(12):1191-205. PubMed ID: 19841877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
    Kekäläinen E; Tuovinen H; Joensuu J; Gylling M; Franssila R; Pöntynen N; Talvensaari K; Perheentupa J; Miettinen A; Arstila TP
    J Immunol; 2007 Jan; 178(2):1208-15. PubMed ID: 17202386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].
    Zhang P; Zhang LN; Zhu FL; Wang Q; Wang XY; Li HY; Liu CM; Gao F; Liu CH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):342-5. PubMed ID: 17892128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood.
    Fujimaki W; Takahashi N; Ohnuma K; Nagatsu M; Kurosawa H; Yoshida S; Dang NH; Uchiyama T; Morimoto C
    Clin Dev Immunol; 2008; 2008():305859. PubMed ID: 18815628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FOXP3+ subset of human CD4+CD8+ thymocytes is immature and subject to intrathymic selection.
    Tuovinen H; Pekkarinen PT; Rossi LH; Mattila I; Arstila TP
    Immunol Cell Biol; 2008; 86(6):523-9. PubMed ID: 18504453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.
    Rensing-Ehl A; Gaus B; Bruckner-Tuderman L; Martin SF
    Exp Dermatol; 2007 Jan; 16(1):13-21. PubMed ID: 17181632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.